A significant breakthrough in cancer research is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in several types of malignancies, https://onelifesocial.com/story7420048/mini-antibodies-restore-p53-the-new-approach-for-tumor-treatment